Cargando…
Comparison and evaluation of lupus nephritis response criteria in lupus activity indices and clinical trials
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with diverse manifestations. Although the approval of new therapies includes only one agent in 50 years, a number of promising new drugs are in development. Lupus nephritis is a dreaded complication of SLE as it is associated with s...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411763/ https://www.ncbi.nlm.nih.gov/pubmed/25927414 http://dx.doi.org/10.1186/s13075-015-0621-6 |